Citation

Williams JF, Lundahl LH. Pediatr. Clin. North Am. 2019; 66(6): 1121-1134.

Affiliation

Substance Abuse Research Division, Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 3901 Chrysler Service Drive, Suite 2A, Detroit, MI 48201, USA.

Copyright

(Copyright © 2019, Elsevier Publishing)

DOI

10.1016/j.pcl.2019.08.013

PMID

31679602

Abstract

Club drugs and "other" abusable substances are briefly overviewed as a reminder about the wide variety of known and unknown substances used by adolescents, the high potential for direct and interactive substance use effects to manifest acutely and chronically, and the vigilance needed to anticipate and recognize the new effects and drug-drug interactions arising as novel substances continue to be custom "designed," manufactured, and marketed to meet substance use trends. This article discusses dextromethorphan, flunitrazepam (Rohypnol), gamma-hydroxybutyrate, inhalants, ketamine, lysergic acid diethylamide, methylenedioxymethamphetamine, phencyclidine, Salvia divinorum (salvia), synthetic cannabinoids, and synthetic cathinones (bath salts).

Copyright © 2019 Elsevier Inc. All rights reserved.

Language: en

Keywords

Adolescents; Club drugs; Designer drugs; Hallucinogens; Inhalants; OTC substances; SBIRT